Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-12-31
1990-06-19
Rivers, Diana G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514274, 544265, 544276, 544277, 544317, A61K 3152, A61K 31505, C07D47334, C07D23947
Patent
active
049354272
ABSTRACT:
Compounds which are active against retroviruses have the following formula
REFERENCES:
patent: 3664991 (1972-05-01), Kaye
patent: 4393064 (1983-07-01), DeGraw, Jr. et al.
patent: 4798833 (1989-01-01), Johansson et al.
Zemlicka, Nucleosides & Nucleotides, 3(3), 245-264 (1984).
Mitsya, et al., Proc. Natl., Acad. Sci. U.S.A., vol. 82, pp. 7096-7100 (10/85).
Phadtare, et al., "Nucleic Acids Symp. Ser." 1987, 18(Symp. Chem. Nucleic Acid Compon., 7th, 1987), pp. 25-28.
Hayashi, et al., Proc. Natl. Acad. Sci. U.S.A., 85(16), pp. 6127-6131 08/88.
Broder Samuel
Hayashi Seiji
Mitsuya Hiroaki
Phadtare Shashikant
Zemlicka Jiri
Benson Robert
Hendricks Glenna
Rivers Diana G.
The United States of America as represented by the Department of
LandOfFree
Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral age does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral age, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral age will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2260537